Published in APMIS on October 01, 2010
Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients. Int J Clin Exp Pathol (2015) 0.75
Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med (2003) 4.30
Extramammary Paget's disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol (1985) 2.60
Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. J Am Coll Surg (2003) 2.22
Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate (2003) 1.73
Extramammary Paget's disease presenting as alopecia neoplastica. J Cutan Pathol (2008) 1.53
Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family. J Natl Cancer Inst (2000) 1.24
Comparison of Mohs micrographic surgery and wide excision for extramammary Paget's Disease: Korean experience. Dermatol Surg (2008) 1.20
Biomarkers for prostate cancer detection. Expert Rev Anticancer Ther (2010) 0.91
Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease. Clin Exp Dermatol (2008) 0.87
Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease. Int J Dermatol (2008) 0.86
Prostate-specific antigen-positive extramammary Paget's disease--association with prostate cancer. APMIS (2008) 0.82
Extramammary Paget's disease--a proliferation of adnexal origin? Histopathology (2006) 0.82
Paget's disease of the scrotum: report of a case with underlying carcinoma of the prostate. Br J Dermatol (1995) 0.81
Evaluation using a combination of lymphatic invasion on D2-40 immunostain and depth of dermal invasion is a strong predictor for nodal metastasis in extramammary Paget's disease. Pathol Int (2008) 0.80
Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate (2010) 1.81
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat Genet (2012) 1.78
External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinoma. J Urol (2012) 1.58
Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells. Exp Hematol (2003) 1.55
Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes. J Urol (2010) 1.49
Defining good candidates for extraperitoneal cystectomy: results from random peritoneum biopsies of 136 cases. Urology (2013) 1.45
Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib. Int J Urol (2011) 1.44
Trypsin catalyzed 16O-to-18O exchange for comparative proteomics: tandem mass spectrometry comparison using MALDI-TOF, ESI-QTOF, and ESI-ion trap mass spectrometers. J Am Soc Mass Spectrom (2003) 1.44
F gene recombination between genotype II and VII Newcastle disease virus. Virus Res (2007) 1.42
Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells. Acta Pharmacol Sin (2010) 1.23
Proteolytic 18O labeling for comparative proteomics: evaluation of endoprotease Glu-C as the catalytic agent. J Proteome Res (2003) 1.23
Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: results from a multicenter study. BMC Cancer (2009) 1.22
Prostate cancer in East Asia: evolving trend over the last decade. Asian J Androl (2015) 1.22
18O2-labeling in quantitative proteomic strategies: a status report. J Proteome Res (2009) 1.21
A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men. Prostate (2012) 1.15
A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer. Prostate (2010) 1.11
Progressive accumulation of epigenetic heterogeneity during human ES cell culture. Epigenetics (2009) 1.09
Age-related sensitivity and pathological differences in infections by 2009 pandemic influenza A (H1N1) virus. Virol J (2011) 1.09
Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines. Mol Cancer Ther (2006) 1.09
Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy. Asian J Androl (2015) 1.08
GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization. Anal Bioanal Chem (2011) 1.06
External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort. Asian J Androl (2012) 1.05
8-Amino-adenosine induces loss of phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Akt kinase: role in induction of apoptosis in multiple myeloma. Mol Cancer Ther (2005) 1.04
Photoacoustic imaging based on MEMS mirror scanning. Biomed Opt Express (2010) 1.03
Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts. Am J Physiol Heart Circ Physiol (2010) 1.02
Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis. J Med Chem (2010) 1.02
Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men. Prostate (2013) 1.00
New N staging system of penile cancer provides a better reflection of prognosis. J Urol (2011) 0.99
Dual regulation of glucocorticoid-induced leucine zipper (GILZ) by the glucocorticoid receptor and the PI3-kinase/AKT pathways in multiple myeloma. J Steroid Biochem Mol Biol (2008) 0.99
Genetic score of multiple risk-associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer. Genes Chromosomes Cancer (2013) 0.98
Performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and the prostate health index (PHI) in a Chinese hospital-based biopsy population. Prostate (2014) 0.97
Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma. J Urol (2012) 0.97
Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels. Asian J Androl (2007) 0.96
Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients. Asian J Androl (2009) 0.96
Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer. Cancer Sci (2014) 0.95
8-amino-adenosine is a potential therapeutic agent for multiple myeloma. Mol Cancer Ther (2004) 0.94
Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease. Neurosci Lett (2009) 0.94
DEXH-Box protein DHX30 is required for optimal function of the zinc-finger antiviral protein. Protein Cell (2010) 0.94
Proteolytic labeling with 18O for comparative proteomics studies: preparation of 18O-labeled peptides and the 18O/16O peptide mixture. Methods Mol Biol (2007) 0.93
Small-angle neutron scattering study of a monoclonal antibody using free-energy constraints. J Phys Chem B (2013) 0.93
Serine lipids of Porphyromonas gingivalis are human and mouse Toll-like receptor 2 ligands. Infect Immun (2013) 0.93
Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9. Stem Cells Dev (2011) 0.92
An elevated serum miR-141 level in patients with bone-metastatic prostate cancer is correlated with more bone lesions. Asian J Androl (2013) 0.92
c-KIT: potential predictive factor for the efficacy of sorafenib in metastatic renal cell carcinoma with sarcomatoid feature. Clin Genitourin Cancer (2012) 0.92
Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer. Urol Oncol (2010) 0.92
An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Virol J (2010) 0.91
Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol (2008) 0.90
Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer. Tumour Biol (2014) 0.90
Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population. PLoS One (2013) 0.90
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma. Onco Targets Ther (2013) 0.90
Metabolic syndrome and renal cell carcinoma. World J Surg Oncol (2014) 0.90
Neurochemical and electrophysiological characteristics of rat striatal neurons in primary culture. J Comp Neurol (2006) 0.89
Tandem parallel fragmentation of peptides for mass spectrometry. Anal Chem (2006) 0.89
The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery. BJU Int (2007) 0.89
Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Asian J Androl (2012) 0.89
Primary yolk sac tumor of seminal vesicle: a case report and literature review. World J Surg Oncol (2012) 0.89
Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease. Neurosci Lett (2011) 0.89
Prospectively packaged ilioinguinal lymphadenectomy for penile cancer: the disseminative pattern of lymph node metastasis. J Urol (2009) 0.89
Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease. Mol Neurodegener (2009) 0.88
PEDF and VEGF-A output from human retinal pigment epithelial cells grown on novel microcarriers. J Biomed Biotechnol (2012) 0.87
Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis. Mol Biol Rep (2013) 0.87
Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries. Asian J Androl (2008) 0.86
Validation of the prognostic value of lymph node ratio in patients with penile squamous cell carcinoma: a population-based study. Int Urol Nephrol (2013) 0.86
Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases. Histopathology (2009) 0.86